(Q78444518)

14 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256472%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

RK-95113, a new angiogenesis inhibitor produced by Aspergillus fumigatus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256472%20AND%20SRC:MED&resulttype=core&format=json

5-Methoxy-4-[2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl (chloroacetyl)carbamate

24 December 2019

main subject

Aspergillus fumigatus

1 reference

inferred from

reverse claim

1 reference

inferred from

reverse claim

angiogenesis inhibitor

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256472%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

4

Masakazu Toi

2 references

https://api.crossref.org/v1/works/http://dx.doi.org/10.1038/ja.2006.97

14 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256472%20AND%20SRC:MED&resulttype=core&format=json

https://api.crossref.org/v1/works/http://dx.doi.org/10.1038/ja.2006.97

24 December 2019

author name string

Yukihiro Asami

series ordinal

1

2 references

14 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256472%20AND%20SRC:MED&resulttype=core&format=json

https://api.crossref.org/v1/works/http://dx.doi.org/10.1038/ja.2006.97

24 December 2019

Gen Okada

series ordinal

3

2 references

14 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256472%20AND%20SRC:MED&resulttype=core&format=json

https://api.crossref.org/v1/works/http://dx.doi.org/10.1038/ja.2006.97

24 December 2019

Hiroyuki Osada

series ordinal

5

2 references

14 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256472%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

November 2006

1 reference

full work available at URL

16 September 2022

https://www.nature.com/articles/ja200697.pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1038/ja.2006.97?email=unpaywall_01@example.com

published in

The Journal of Antibiotics

2 references

https://api.crossref.org/v1/works/http://dx.doi.org/10.1038/ja.2006.97

14 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256472%20AND%20SRC:MED&resulttype=core&format=json

https://api.crossref.org/v1/works/http://dx.doi.org/10.1038/ja.2006.97

24 December 2019

volume

59

2 references

14 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256472%20AND%20SRC:MED&resulttype=core&format=json

https://api.crossref.org/v1/works/http://dx.doi.org/10.1038/ja.2006.97

24 December 2019

issue

11

2 references

14 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256472%20AND%20SRC:MED&resulttype=core&format=json

https://api.crossref.org/v1/works/http://dx.doi.org/10.1038/ja.2006.97

24 December 2019

page(s)

724-728

2 references

14 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256472%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1038/ja.2006.97?email=unpaywall_01@example.com

access restriction status

open access

1 reference

inferred from online access status

exact match

https://scigraph.springernature.com/pub.10.1038/ja.2006.97

0 references

cites work

Clinical translation of angiogenesis inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.97

7 January 2021

Angiogenesis modulation in cancer research: novel clinical approaches

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.97

7 January 2021

Angiogenesis as a therapeutic target

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.97

7 January 2021

Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.97

7 January 2021

https://api.crossref.org/works/10.1038%2FJA.2006.97

1 reference

7 January 2021

Epoxyquinol A, a highly functionalized pentaketide dimer with antiangiogenic activity isolated from fungal metabolites.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.97

7 January 2021

Epoxyquinol B, a fungal metabolite with a potent antiangiogenic activity

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.97

7 January 2021

Epoxytwinol A, a novel unique angiogenesis inhibitor with C2 symmetry, produced by a fungus.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.97

7 January 2021

Azaspirene: a novel angiogenesis inhibitor containing a 1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione skeleton produced by the fungus Neosartorya sp

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.97

7 January 2021

RK-805, an endothelial-cell-growth inhibitor produced by Neosartorya sp., and a docking model with methionine aminopeptidase-2

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.97

7 January 2021

Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.97

7 January 2021

A new angiogenesis inhibitor, FR-111142

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.97

7 January 2021

Structure of Sch 528647: a new antitumor antibiotic related to fumagillin.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.97

7 January 2021

Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.97

7 January 2021

Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.97

7 January 2021

The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.97

7 January 2021

Structure of human methionine aminopeptidase-2 complexed with fumagillin

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.97

7 January 2021

Depletion of methionine aminopeptidase 2 does not alter cell response to fumagillin or bengamides

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.97

7 January 2021

Methionine aminopeptidases type I and type II are essential to control cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.97

7 January 2021

Fumagillin suppresses HIV-1 infection of macrophages through the inhibition of Vpr activity.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.97

7 January 2021

https://api.crossref.org/v1/works/http://dx.doi.org/10.1038/ja.2006.97

Identifiers

2 references

14 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256472%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

24 December 2019

1018510330

0 references

1 reference